ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 194 filers reported holding ARRAY BIOPHARMA INC in Q4 2017. The put-call ratio across all filers is 0.42 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $95,741,000 | +90.0% | 2,066,511 | 0.0% | 0.03% | +87.5% |
| Q1 2019 | $50,382,000 | +82.0% | 2,066,511 | +6.4% | 0.02% | +60.0% |
| Q4 2018 | $27,689,000 | -6.3% | 1,943,059 | 0.0% | 0.01% | 0.0% |
| Q3 2018 | $29,535,000 | +0.1% | 1,943,059 | +10.5% | 0.01% | 0.0% |
| Q2 2018 | $29,516,000 | +2.8% | 1,758,975 | 0.0% | 0.01% | 0.0% |
| Q1 2018 | $28,706,000 | +27.5% | 1,758,975 | 0.0% | 0.01% | +25.0% |
| Q4 2017 | $22,515,000 | +4.1% | 1,758,975 | 0.0% | 0.01% | 0.0% |
| Q3 2017 | $21,635,000 | +88.2% | 1,758,975 | +28.1% | 0.01% | +60.0% |
| Q2 2017 | $11,493,000 | +110.3% | 1,373,168 | +124.6% | 0.01% | +150.0% |
| Q1 2017 | $5,465,000 | +1142.0% | 611,338 | +1122.7% | 0.00% | – |
| Q4 2016 | $440,000 | +36.6% | 50,000 | 0.0% | 0.00% | – |
| Q3 2016 | $322,000 | – | 50,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 16,459,128 | $234,543,000 | 9.43% |
| APIS CAPITAL ADVISORS, LLC | 490,000 | $6,983,000 | 9.36% |
| BVF INC/IL | 4,744,062 | $67,603,000 | 8.84% |
| First Light Asset Management, LLC | 2,853,826 | $40,667,000 | 6.48% |
| SECTORAL ASSET MANAGEMENT INC | 2,165,767 | $30,862,000 | 4.20% |
| GREAT POINT PARTNERS LLC | 1,850,000 | $26,363,000 | 3.33% |
| PACIFIC VIEW ASSET MANAGEMENT, LLC | 146,952 | $2,092,000 | 2.46% |
| Birchview Capital, LP | 168,000 | $2,394,000 | 2.26% |
| X-Square Capital, LLC | 180,554 | $2,572,000 | 2.02% |
| FINANCIAL & INVESTMENT MANAGEMENT GROUP LTD | 295,610 | $4,212,000 | 1.54% |